Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Safety Information For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Bumex (bumetanide) Tablets & Bumex (bumetanide) Injection, 0.25, 1 and 2 mg & 0.25 mg/mL, respectively, Hoffmann-La Roche NDA 18-225/S-018 & 019 & 18-226/S-024 & 025 10/29/02 11/19/02 3/7/03 Bumex (bumetanide) Tablets, 0.25, 1 and 2 mg, Hoffmann-La Roche NDA 18-225/S22 BUMETANIDE Injection 0.25MG/ML BUMETANIDE Abbott | 074332 BUMETANIDE Injection 0.25MG/ML BUMETANIDE Abbott | 074441 BUMETANIDE Injection 0.25MG/ML BUMETANIDE Bedford | 074613 BUMETANIDE Injection 0.25MG/ML BUMETANIDE Gensia Sicor | 018226 BUMETANIDE Injection 0.25MG/ML BUMEX ROCHE 074700 BUMETANIDE Tablet; 0.5MG BUMETANIDE Eon | 074700 BUMETANIDE Tablet; 1MG BUMETANIDE Eon | 074700 BUMETANIDE Tablet; 2MG BUMETANIDE Eon | 074225 BUMETANIDE Tablet; 0.5MG BUMETANIDE Ivax | 074225 BUMETANIDE Tablet; 1MG BUMETANIDE Ivax | 074225 BUMETANIDE Tablet; 2MG BUMETANIDE Ivax | 018225 BUMETANIDE Tablet; 0.5MG BUMEX ROCHE | 018225 BUMETANIDE Tablet; 1MG BUMEX ROCHE | 018225 BUMETANIDE Tablet; 2MG BUMEX ROCHE | Bumetanide Injection, Baxter Healthcare Corp., Approval | Bumex (bumetanide) Tablets, Validus Pharmaceuticals, Labeling Revision ^ FDA's latest approval appears at the bottom of this list. ^                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | Best Phone © 2012 Betterchem.com